Byotrol PLC Appointment of CFO & Award of Options (2020A)
28 May 2019 - 4:01PM
UK Regulatory
TIDMBYOT
RNS Number : 2020A
Byotrol PLC
28 May 2019
28 May 2019
Byotrol plc
("Byotrol", or the "Company")
Appointment of Chief Financial Officer
Award of Options
Byotrol plc, the AIM quoted anti-microbial technology company,
is pleased to announce the appointment of Nic Hellyer as CFO and
Executive Director of the Company with immediate effect.
Nic is a Chartered Accountant (FCA) and former investment banker
with over 25 years' corporate finance experience, mostly at UBS and
HSBC, managing corporate development, M&A and fund raisings for
growth and entrepreneurial companies (both public and private).
He is being employed on a part-time basis by the Company
alongside his other business interests, which include a part-time
CFO role at Pelatro plc, another AIM-listed company.
The Company has today granted Nic Hellyer options over 2,000,000
shares under the Byotrol plc approved share option scheme at a
strike price of 2.6p. These options are exercisable in three
tranches from 28 May 2020, 2021 and 2022 subject to the Company's
share price reaching hurdles of 3.5p, 5.5p and 7.5p.
At the date of this announcement, Mr Hellyer does not have any
other beneficial interest in the ordinary shares of the
Company.
In addition to the above, the Company is issuing a further
1,000,000 shares to a new employee under the Byotrol plc share
option scheme, on the same terms as detailed above.
John Langlands, Chairman of the Company, said,
"We are delighted to welcome Nic to the Board of the Byotrol. He
has a wealth of experience from his time in the investment banking
world, including extensive experience in the smaller company
environment, and has directly relevant experience as a Finance
Director for an SME on AIM. His skills will be invaluable to us as
we continue to grow and develop Byotrol."
Current directorships and/or partnerships Former directorships and/or
of Nicholos James Hellyer (56): partnerships (within the last
five years):
Defenx plc The Marketing Group plc
Pelatro Plc
Reeflive Limited
Weyland-Yutani Property Management
Limited
Save for the disclosures above, there are no further disclosures
to be made in accordance with Rule 17 and Schedule 2(g) of the AIM
Rules.
The information communicated in this announcement is inside
information for the purposes of Article 7 of Regulation
596/2014.
Enquiries:
Byotrol plc 01925 742 000
John Langlands - Chairman
David Traynor - Chief Executive
finnCap Ltd 020 7220 0500
Geoff Nash / Kate Bannatyne - Corporate Finance
Richard Chambers - ECM
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer
of antimicrobial technologies, identifying, developing, formulating
and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful,
broad-spectrum efficacy, optimised against commonly-occurring and
industry-specific pathogens.
Founded in 2005, the Company seeks to develop and commercialise
advanced antimicrobial technologies that create easier, safer and
cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk
Accordingly, the Company makes the following announcement and
notification in accordance with the EU Market Abuse Regulation (No
596/2014):
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Nic Hellyer
------------------------------- --------------------------------------
2. Reason for the Notification
-----------------------------------------------------------------------
a) Position/status Chief Financial Officer
------------------------------- --------------------------------------
b) Initial notification/Amendment Initial
------------------------------- --------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Byotrol Plc
------------------------------- --------------------------------------
b) LEI 213800AJMTSTIPA59A34
------------------------------- --------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-----------------------------------------------------------------------
a) Description of the options over ordinary shares of 0.25p
Financial instrument, each
type of instrument
Identification code GB00B0999995
------------------------------- --------------------------------------
b) Nature of the transaction Award of Options to subscribe for
Ordinary Shares
------------------------------- --------------------------------------
c) Price(s) and volume(s) Volume - 2,000,000
Exercise Price - 2.6 pence
------------------------------- --------------------------------------
d) Aggregated information: See 4(c) above
------------------------------- --------------------------------------
e) Date of the transaction 28 May 2019
------------------------------- --------------------------------------
f) Place of the transaction Outside of a trading venue
------------------------------- --------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCPGUCUAUPBGMC
(END) Dow Jones Newswires
May 28, 2019 02:01 ET (06:01 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024